Key result
Lesion-homing delivery via stents, balloons, and nanoparticles enhances therapeutic efficacy in atherosclerosis.
Answers are grounded in this paper and cite their sources.
Atherosclerosis, a chronic inflammatory disease of vascular wall, is a progressive pathophysiological process with lipids oxidation/depositing initiation and innate/adaptive immune responses. The coordination of multi systems covering oxidative stress, dysfunctional endothelium, diseased lipid uptake, cell apoptosis, thrombotic and pro-inflammatory responding as well as switched SMCs contributes to plaque growth. In this circumstance, inevitably, targeting these processes is considered to be effective for treating atherosclerosis. Arriving, retention and working of payload candidates mediated by targets in lesion direct ultimate therapeutic outcomes. Accumulating a series of scientific studies and clinical practice in the past decades, lesion homing delivery strategies including stent/balloon/nanoparticle-based transportation worked as the potent promotor to ensure a therapeutic effect. The objective of this review is to achieve a very brief summary about the effective therapeutic methods cooperating specifical targets and positioning-delivery strategies in atherosclerosis for better outcomes.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted a review in Atherosclerosis. Plaque-positioned delivery strategies and targeted therapies was evaluated. Lesion-homing delivery strategies, including stent, balloon, and nanoparticle-based transportation, act as potent promoters to ensure therapeutic effects in the treatment of atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: